Because February was such a strong month for equities��nd for Fidelity�� stock funds��he January sell-off is looking more like an aberration and not a harbinger of another market apocalypse, suggests John Bonnanzio in Fidelity Monitor & Insight.
While fourth-quarter consumer spending has been revised down to 2.6% from 3.3%, that�� still the fastest increase in seven quarters. Also, businesses are spending more on equipment, and US exports rose 9.4%.
Among growth stocks, the number of companies booking revenue growth appears to be rising. This should lend support to growth stocks as the year progresses. As such, we are modestly rebalancing our style exposures to emphasize ��rowthier��stocks.
These types of stocks are held in Fidelity Blue Chip Growth (US:FBGRX). Unless his fund implodes over the next few months, Sonu Kalra will look back over his five-year tenure on this large-cap growth fund and likely boast that he has beaten around 90% of his peers.
Best Beverage Companies To Invest In Right Now: Guided Therapeutics Inc (GTHP)
Guided Therapeutics, Inc., incorporated on October 27, 1992, is a medical technology company focused on developing medical devices. The Company�� primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.
The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions. The product is expected to incorporate a single-use, disposable calibration and alignment component.
The Company competes with Qiagen, MediSpectra, Inc., Merck & Co., Inc., and GlaxoSmithKline PLC.
Advisors' Opinion:- [By CRWE]
Today, GTHP remains (0.00%) +0.000 at $.710 with 44,700 shares in play thus far (ref. google finance Delayed: 11:42AM EDT August 21, 2013).
Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.
Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.
- [By CRWE]
Last Friday, GTHP had shed (-2.16%) down -0.015 at $.679 with 39,538 shares in play at the close (ref. google finance August 23, 2013 ��Close).
Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.
Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.
Top 5 Healthcare Equipment Companies To Watch In Right Now: Hanwha SolarOne Co. Ltd.(HSOL)
Hanwha Solarone Co., Ltd., an investment holding company, engages in the manufacture and sale of silicon ingots, silicon wafers, and PV cells and modules. The company also offers mono crystalline and multi crystalline silicon cells; and provides PV module processing services. It sells its products to solar power system integrators and distributors primarily in Germany, Italy, Australia, the United States, the Czech Republic, Spain, and China. The company was formerly known as Solarfun Power Holdings Co., Ltd. and changed its name to Hanwha SolarOne Co., Ltd. in December 2010. Hanwha Solarone Co., Ltd. was founded in 2004 and is based in Qidong, the People?s Republic of China.
Advisors' Opinion:- [By Rebecca McClay]
The tech market's news today includes a plunge in Hanwha SolarOne Co. Ltd. (Nasdaq: HSOL) shares, which are down 5% in morning trade after its second-quarter loss narrowed to $0.32 per share from a loss of $0.43 in Q1.
- [By Travis Hoium]
News and notes
Hanwha SolarOne (NASDAQ: HSOL ) announced another $100 million in financing this week, this time a term loan from the Export-Import Bank of Korea. � - [By Roberto Pedone]
One under-$10 stock that's starting to move within range of triggering a big breakout trade is Hanwha SolarOne (HSOL), which manufactures a number of silicon ingots, PV cells and PV modules using advanced manufacturing process technologies. This stock has been on fire so far in 2013, with shares up 301%.
If you take a look at the chart for Hanwha SolarOne, you'll notice that this stock has been uptrending strong for the last month and change, with shares moving higher from its low of $2.60 to its recent high of $4.28 a share. During that uptrend, shares of HSOL have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of HSOL within range of triggering a big breakout trade.
Traders should now look for long-biased trades in HSOL if it manages to break out above its 52-week high at $4.28 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.61 million shares. If that breakout triggers soon, then HSOL will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $6 to $7 a share.
Traders can look to buy HSOL off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $3.40 a share, or near more support at $3.35 a share. One can also buy HSOL off strength once it clears $4.28 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Travis Hoium]
What: Solar stocks are shooting higher again today as the strong run in 2013 continues. LDK Solar (NYSE: LDK ) , Canadian Solar (NASDAQ: CSIQ ) , Yingli Green Energy (NYSE: YGE ) , Hanwha SolarOne (NASDAQ: HSOL ) , and JinkoSolar (NYSE: JKS ) led the way, gaining between 10% and 22% today.
Top 5 Healthcare Equipment Companies To Watch In Right Now: C&J Energy Services Inc (CJES)
C&J Energy Services, Inc., incorporated on December 15, 2010, is a provider of hydraulic fracturing, coiled tubing, wireline and other complementary services with a focus on complex, technically demanding well completions. The Company also manufactures and repairs equipment to fulfill its internal needs and for third-party companies in the energy services industry. The Company operates in three reportable segments: Stimulation and Well Intervention Services, Wireline Services and Equipment Manufacturing.
The Company provides hydraulic fracturing coiled tubing and related well intervention services through its Stimulation and Well Intervention Services segment to oil and natural gas exploration and production companies. On June 7, 2012, the Company acquired Casedhole Holdings, Inc. and its operating subsidiaries, including Casedhole Solutions, Inc.
Stimulation and Well Intervention Services
The Company's Stimulation and Well Intervention Services segment provides hydraulic fracturing and coiled tubing and other well intervention services, with a focus on complex, technically demanding well completions. The Company's customers use the Company's hydraulic fracturing services to enhance the production of oil and natural gas from formations with low permeability, which restricts the natural flow of hydrocarbons. Hydraulic fracturing involves pumping a fluid down a well casing or tubing at sufficient pressure to cause the underground producing formation to fracture, allowing the oil or natural gas to flow more freely. The Company's engineering staff also provides technical evaluation, job design and fluid recommendations for the Company's customers as an integral element of its fracturing service. The Company's engineering staff also provides technical evaluation, job design and fluid recommendations for the Company's customers as an integral element of its fracturing service.
Wireline Services
The Company's Wireline Services segment p! rovides cased-hole wireline and other complementary services. Its services includes logging, perforating, pipe recovery, pressure testing and pumpdown services, which are critical throughout a well's life cycle.
Equipment Manufacturing
The Company's Equipment Manufacturing segment constructs oilfield equipment, including hydraulic fracturing pumps, coiled tubing units, pressure pumping units and other equipment for the Company's Stimulation and Well Intervention Services and Wireline Services segments as well as for third-party customers in the energy services industry. This segment also provides equipment repair services and oilfield parts and supplies to the energy services industry and to meet the Company's own internal needs.
The Company competes with Halliburton, Schlumberger, Baker Hughes, Weatherford International, RPC, Inc., Pumpco, an affiliate of Superior Energy Services, Frac Tech, Stewart & Stevenson, Enerflow Industries Inc., United Engines Manufacturing, Dragon Products and National Oilwell Varco, Inc.
Advisors' Opinion:- [By Matt DiLallo]
C&J Energy Services (NYSE: CJES )
One of the more interesting purchases this quarter is the $7.4 million Soros poured into C&J Energy Services. The oilfield service company specializes in complex well completions, making it an important company for extracting ever-harder-to-reach oil and gas. With operations spanning the most active shale plays, an investment in C&J is one that benefits as oil and gas companies drill more wells using even more complex hydraulic fracturing techniques. - [By Aaron Levitt]
For investors, the choice is clear — you need to focus globally when it comes to oil stocks. North American-focused oil stocks like C&J Energy (CJES) and Basic Energy Services (BAS) might not be up to snuff in such a highly challenging pricing environment.
- [By Roberto Pedone]
C&J Energy Services (CJES), through its subsidiaries, provides hydraulic fracturing, coiled tubing, wireline and other complementary services to oil and gas exploration and production companies in the U.S. This stock closed up 2.9% at $29.55 in Wednesday's trading session.
Wednesday's Volume: 1.95 million
Three-Month Average Volume: 879,264
Volume % Change: 161%From a technical perspective, CJES spiked notably higher here right above its 200-day moving average of $28.06 and back above its 50-day moving average of $29.55 with above-average volume. This move to the upside on Wednesday also pushed shares of CJES into breakout territory, since the stock took out some near-term overhead resistance at $29.27. Shares of CJES are now starting to trend within range of triggering another breakout trade. That trade will hit if CJES manages to clear Wednesday's intraday high of $29.69 to some more near-term overhead resistance at $30.16 with high volume.
Traders should now look for long-biased trades in CJES as long as it's trending above its 200-day at $28.06 and then once it sustains a move or close above those breakout levels with volume that hits near or above 879,264 shares. If that breakout develops soon, then CJES will set up to re-test or possibly take out its next major overhead resistance levels at $31.50 to $33
- [By Lee Jackson]
C&J Energy Services Inc. (NYSE: CJES) undertook an aggressive expansion plan for 2013. That strategy culminated in several deals during the fourth quarter and further plans for 2014. The domestic hydraulic fracturing specialist has spent the past couple of years expanding the business line and, surprisingly, building new equipment. Now with natural gas inventories plunging to five-year lows, C&J Energy is positioned to take advantage of a market where utilization is already firming. Jefferies price target holds steady at $28, and the consensus estimate is $25. Shares closed Friday at $24.50.
Top 5 Healthcare Equipment Companies To Watch In Right Now: Jinpan International Limited(JST)
Jinpan International Limited engages in the design and manufacture of cast resin transformers for voltage distribution equipment. Its cast resin transformers allow high voltage transmissions of electricity to be distributed to various locations in lower, more usable voltages. The company provides medium voltage cast resin transformers for various end uses and applications, including industrial, infrastructure, and municipal projects, such as factories, real estate developments, airports, and subway systems. It also offers switchgears, which enable operators of a power distribution network to switch equipment in and out of the network; line reactors that limit current, filter waveforms, and attenuate electrical noise and harmonics associated with the inverter and driver output of wind powered turbines; and unit substations, which are integrated assemblies comprising high voltage switchgear, a transformer, a low voltage switchgear, a power meter, and a power factor compensat ion device interconnected with cables or buss bars. The company?s unit substations function as miniature power distribution stations and are used in applications related to the construction and maintenance of city power networks. Jinpan International sells its products in the People?s Republic of China, the United States, and Europe. The company was founded in 1993 and is headquartered in Haikou, the People's Republic of China.
Advisors' Opinion:- [By CRWE]
Jinpan International Ltd (Nasdaq:JST), a leading designer, manufacturer, and distributor of cast resin dry type transformers, recently reported that its subsidiary Hainan Jinpan Electric Co. Ltd. successfully developed a 40,000KVA / 35KV cast resin dry type power transformer. The Company has shipped the transformer to the customer’s site in China’s Anhui province for installation in a transformer substation that will deliver power to gas liquification systems.
No comments:
Post a Comment